相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antifungal and Anti-Virulent Activity of Origanum majorana L. Essential Oil on Candida albicans and In Vivo Toxicity in the Galleria mellonella Larval Model
Banu Kaskatepe et al.
MOLECULES (2022)
Isolation and Characterization of a New Phage Infecting Elizabethkingia anophelis and Evaluation of Its Therapeutic Efficacy in vitro and in vivo
Shih-Yi Peng et al.
FRONTIERS IN MICROBIOLOGY (2020)
Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model
Lei Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Diversity in prevalence and characteristics of ESBL/pAmpC producing E. coli in food in Germany
Annemarie Kaesbohrer et al.
VETERINARY MICROBIOLOGY (2019)
Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections
Yu Lin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
Christine Rohde et al.
VIRUSES-BASEL (2018)
Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
Yunfen Hua et al.
FRONTIERS IN MICROBIOLOGY (2018)
Isolation, characterization and in vivo efficacy of Escherichia phage myPSH1131
Prasanth Manohar et al.
PLOS ONE (2018)
Editorial: Phage Therapy: Past, Presentand Future
Stephen T. Abedon et al.
FRONTIERS IN MICROBIOLOGY (2017)
In vitro activity of three commercial bacteriophage cocktails against multidrug-resistant Escherichia coli and Proteus spp. strains of human and non-human origin
Odette J. Bernasconi et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2017)
Emergence and mechanism of carbapenem-resistant Escherichia coli in Henan, China, 2014
Wen-juan Liang et al.
Journal of Infection and Public Health (2017)
CHEMICAL COMPOSITION AND ANTIMICROBIAL ACTIVITY OF THE COMMERCIAL ORIGANUM ONITES L. OIL AGAINST NOSOCOMIAL CARBAPENEM RESISTANT EXTENDED SPECTRUM BETA LACTAMASE PRODUCER ESCHERICHIA COLI ISOLATES
Banu Kaskatepe et al.
ACTA BIOLOGICA HUNGARICA (2017)
Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates
Hugo Oliveira et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Characterization of potential lytic bacteriophage against Vibrio alginolyticus and its therapeutic implications on biofilm dispersal
Dakshinamurthy Sasikala et al.
MICROBIAL PATHOGENESIS (2016)
In vitro Effectiveness of Commercial Bacteriophage Cocktails on Diverse Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains
Aycan Gundogdu et al.
FRONTIERS IN MICROBIOLOGY (2016)
'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages
Janet Y. Nale et al.
FRONTIERS IN MICROBIOLOGY (2016)
Bacteriophages as Potential Treatment for Urinary Tract Infections
Wilbert Sybesma et al.
FRONTIERS IN MICROBIOLOGY (2016)
In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
Tomasz Olszak et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Efficiency of bacteriophage therapy against Cronobacter sakazakii in Galleria mellonella (greater wax moth) larvae
Reza Abbasifar et al.
ARCHIVES OF VIROLOGY (2014)
Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
Fan Peng et al.
BMC MICROBIOLOGY (2014)
Susceptibility of extended-spectrum- -lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages
Deirdre Fitzgerald-Hughes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens
Tania Mareike Viertel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
Xavier Wittebole et al.
VIRULENCE (2014)
Bacteriophages φMR299-2 and φNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells
Debebe Alemayehu et al.
MBIO (2012)
Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions
Julia Garbe et al.
BMC MICROBIOLOGY (2010)
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Laurent Debarbieux et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Efficacy of Bacteriophage Therapy in a Model of Burkholderia cenocepacia Pulmonary Infection
Lisa A. Carmody et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia Complex
Kimberley D. Seed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
Maya Merabishvili et al.
PLOS ONE (2009)
Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved
EF Boyd et al.
TRENDS IN MICROBIOLOGY (2002)
分享论文
